You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 128 No. 1, January 2010 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Laboratory Sciences
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Cataracts/ Lens
 •Endophthalmitis
 •Ophthalmological Procedures, Other
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Subconjunctival Delivery of Antibiotics in a Controlled-Release System

A Novel Anti-infective Prophylaxis Approach for Cataract Surgery

José A. Cardillo, MD; Fernando Paganelli, MD; Luiz A. S. Melo Jr, MD; Arnobio A. Silva Jr, PharmD; Antonio C. Pizzolitto, PharmD; Anselmo G. Oliveira, PharmD, PhD; the Brazilian Ocular Pharmacology and Pharmaceutical Technology Research Group

Arch Ophthalmol. 2010;128(1):81-87. doi:10.1001/archophthalmol.2009.352

Objective  To compare the efficacy of subconjunctival injection of a combination of triamcinolone and ciprofloxacin hydrochloride, 2 mg/0.1 mL, in a controlled-release system (DuoCat) with that of ciprofloxacin hydrochloride, 0.3%, eyedrops for infection prophylaxis.

Methods  Rabbit eyes were injected subconjunctivally with a combination of triamcinolone and ciprofloxacin hydrochloride, 2 mg/0.1 mL, or ciprofloxacin hydrochloride, 2 mg/0.1 mL, alone. The aqueous and vitreous humor pharmacokinetic profiles were compared with those of a single drop of ciprofloxacin hydrochloride, 0.3%, 6 times daily. In 45 rabbits, Staphylococcus aureus was injected into the anterior chamber: 15 randomly received 1 drop of ciprofloxacin hydrochloride, 0.3%, every 4 hours during 24 hours; 15 received drops of balanced salt solution; and 15 received a combination of triamcinolone and ciprofloxacin hydrochloride, 2 mg/0.1 mL. After 24 hours, endophthalmitis scores were recorded, aqueous and vitreous humors underwent culture, and histologic analysis was performed.

Results  The combined triamcinolone and ciprofloxacin treatment allowed higher intraocular levels of ciprofloxacin. The median endophthalmitis clinical scores for the combination of triamcinolone and ciprofloxacin and ciprofloxacin-only eyedrop groups were equivalent (P = .42) and were significantly lower than those of the balanced salt solution group (P < .001). The culture was negative for S aureus in the combined triamcinolone and ciprofloxacin and ciprofloxacin eyedrop regimens. No adverse effects were observed with either route.

Conclusions  Ciprofloxacin eyedrops and combined triamcinolone and ciprofloxacin were equally tolerated and efficacious. The combined triamcinolone and ciprofloxacin treatment may eliminate noncompliance issues and may prove to be a valuable clinical tool for surgical prophylaxis.

Clinical Relevance  The combined triamcinolone and ciprofloxacin treatment may be a new useful strategy for surgical prophylaxis.


Author Affiliations: Hospital de Olhos de Araraquara, Araraquara (Drs Cardillo and Paganelli); Department of Ophthalmology, Federal University of São Paulo–UNIFESP-EPM (Drs Cardillo, Paganelli, and Melo); Department of Ophthalmology, University of Araraquara–UNIARA, Araraquara (Drs Cardillo and Paganelli); and School of Pharmaceutical Sciences, State of São Paulo University–UNESP, Araraquara (Drs Silva, Pizzolitto, and Oliveira), São Paulo, Brazil.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2010 American Medical Association. All Rights Reserved.